시장보고서
상품코드
2127331

글루카곤 유사 펩티드-1(GLP-1) 동반 식품 및 영양 시장 보고서(2026년)

Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Global Market Report 2026

발행일: | 리서치사: 구분자 The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

가격
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 4,490 금액 안내 화살표 ₩ 6,260,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 금액 안내 화살표 ₩ 9,049,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 금액 안내 화살표 ₩ 11,837,000
※ 부가세 별도
한글목차
영문목차

글루카곤 유사 펩티드-1(GLP-1) 동반 식품 및 영양 시장 규모는 최근 비약적으로 성장하고 있습니다. 이 시장은 2025년 32억 달러에서 2026년에는 41억 4,000만 달러로, CAGR 29.2%로 성장할 전망입니다. 이러한 성장은 전 세계 비만 및 2형 당뇨병 유병률 증가, 약물 기반 체중 관리 요법의 보급 확대, 기능성 식품 및 영양 보조제 산업의 성장, GLP-1 수용체 작용제의 초기 임상시험 성공, 그리고 대사 건강 관리에 대한 소비자 인식의 고취에 기인한 것으로 보입니다.

글루카곤 유사 펩티드-1(GLP-1) 동반 식품 및 영양 시장 규모는 향후 몇 년간 비약적인 성장이 전망되고 있습니다. 2030년에는 116억 6,000만 달러에 이르고, CAGR은 29.6%를 나타낼 전망입니다. 예측 기간 동안의 이러한 성장은 체중 관리 및 당뇨병 치료 분야에서 GLP-1 제제의 채택 확대, 맞춤형 영양 및 정밀 식단 계획에 대한 수요 증가, 디지털 헬스 및 영양 관리 플랫폼의 성장, 푸드테크와 생명공학 혁신의 융합 진전,예방 의료 및 대사 웰니스 프로그램의 확대에 기인한 것으로 보입니다. 예측 기간 동안의 주요 동향으로는 GLP-1 요법을 지원하기 위한 맞춤형 대사 영양 계획, 식욕 조절에 중점을 둔 포만감을 높이는 기능성 식품의 배합, 혈당 안정화를 목적으로 한 저혈당지수(GI) 식단 시스템,체중 관리를 지원하기 위한 마이크로바이옴에 최적화된 식이 중재, 근육 유지를 위한 단백질 강화·고영양가 GLP-1 병용 식단 등이 있습니다.

비만율의 상승으로 인해 향후 글루카곤 유사 펩타이드-1(GLP) 동반 식품 및 영양 시장의 성장이 가속화될 것으로 예측됩니다. 비만이란 체지방의 과도한 축적이 특징인 병태로, 건강에 악영향을 미치며 당뇨병, 심혈관 질환, 고혈압 등의 질환 위험을 높일 가능성이 있습니다. 비만 유병률의 상승은 주로 고칼로리 가공식품이나 당분이 많은 식품의 과다 섭취와 같은 불건강한 식습관, 그리고 운동 부족에 의해 유발되고 있습니다. 글루카곤 유사 펩타이드-1(GLP) 동반 식품 및 영양 제품은 GLP-1 기반 체중 감량 요법을 보완하는 역할을 합니다. 고단백·고식이섬유 영양 배합을 통해 포만감을 높이고, 과도한 식사 섭취를 억제하며, 칼로리 제한 중에도 제지방근육량을 유지하도록 지원함으로써 비만 관리에 기여합니다. 예를 들어, 2025년 5월, 영국 정부 기관인 건강 개선 및격차 해소국(Office for Health Improvement and Disparities)에 따르면, 2023년부터 2024년까지 잉글랜드 18세 이상 성인의 약 64.5%가 과체중 또는 비만인 것으로 추정된 반면, 2022년부터 2023년까지서는 64.0%였습니다. 따라서 비만율 증가가 경구용 글루카곤 유사 펩타이드-1(GLP) 동반 식품 및 영양 시장의 성장을 견인하고 있습니다.

글루카곤 유사 펩타이드-1(GLP) 동반 식품 및 영양 시장에서 사업을 전개하는 주요 기업들은 식단의 균형을 개선하고 근육량 감소를 방지하며, GLP-1 기반 체중 감량 요법에 수반되는 잠재적인 영양 결핍을 해결하기 위해, 단백질과 식이섬유가 풍부한 동반 식품 조합 등 혁신적인 영양 지원 솔루션 개발에 주력하고 있습니다. 단백질과 식이섬유가 풍부한 동반 식품 조합은 특히 식사 섭취량이 감소한 분이나 특정 영양 요구 사항이 있는 분을 대상으로, 영양을 지원하고 포만감을 높이며 소화기 건강을 개선하기 위해 단백질과 식이섬유 함량을 높여 특별히 배합된 식품입니다. 예를 들어, 2024년 2월,미국에 본사를 둔 영양·웰니스 기업 허벌라이프(Herbalife Ltd.)는 GLP-1 및 기타 체중 감량 약물을 복용 중인 분들을 지원하기 위해 설계된 식품과 보충제의 조합 제품 시리즈인 ‘허벌라이프 GLP-1 뉴트리션 컴패니언’을 출시했습니다. 이 제품 시리즈에는 단백질 쉐이크를 기반으로 한 제품과 식이섬유가 풍부한 영양 블렌드가 포함되어 있어, 사용자가 일일 영양 요구량을 충족하는 데 도움을 주는 동시에 근육 유지 및 소화기 건강을 지원하는 것을 목표로 합니다. 또한, 이 솔루션에는 유통업체을 통한 커뮤니티 기반의 영양 지도도 포함되어 있어, 체중 감량 치료 중 및 치료 후 더 건강한 식습관을 장려함으로써 약물 치료를 넘어선 장기적인 라이프스타일 개선을 지원하고 있습니다.

자주 묻는 질문

  • 글루카곤 유사 펩티드-1(GLP-1) 동반 식품 및 영양 시장 규모는 어떻게 변화할 것으로 예상되나요?
  • 글루카곤 유사 펩티드-1(GLP-1) 동반 식품 및 영양 시장의 성장은 어떤 요인에 기인하나요?
  • 비만율 상승이 GLP-1 동반 식품 및 영양 시장에 미치는 영향은 무엇인가요?
  • GLP-1 동반 식품 및 영양 시장에서 주요 기업들은 어떤 혁신적인 솔루션을 개발하고 있나요?
  • 허벌라이프는 GLP-1 동반 식품 및 영양 시장에서 어떤 제품을 출시했나요?

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, COVID-19 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 시장에서 주목 받는 스타트업

제40장 주요 인수합병(M&A)

제41장 시장 잠재력이 높은 국가, 부문, 전략

제42장 부록

JHS 26.09.15

Glucagon-like peptide-1 (GLP-1) companion food and nutrition refers to specially formulated dietary products and nutritional approaches created to complement and improve the effectiveness of GLP-1-based treatments for weight management and metabolic health. These foods and nutritional formulations are generally designed to promote satiety, maintain stable blood glucose levels, and support the physiological effects of GLP-1 hormones.

The primary product types of glucagon-like peptide-1 (GLP-1) companion food and nutrition include high-protein foods, glucagon-like peptide-1 optimized meal kits, nutritional supplements, functional beverages, and low-calorie snacks. High-protein foods are nutritional products developed with increased protein content to promote satiety, preserve muscle mass, and support balanced nutrition. These offerings are intended for consumers such as glucagon-like peptide-1 drug users, individuals seeking weight management, diabetic patients, and general wellness consumers. They emphasize formulations including satiety support products, muscle maintenance products, micronutrient-enhanced products, hydration support products, and digestive comfort products, and are distributed through retail pharmacies, e-commerce platforms, specialty health stores, and direct-to-consumer channels.

Tariffs are influencing the glucagon-like peptide-1 (GLP-1) companion food and nutrition market by increasing the cost of imported specialty ingredients, functional food additives, and nutritional formulation technologies used to develop metabolic health-focused products. This is placing cost pressure on segments such as functional beverages and nutritional supplements, where supply chains for bioactive compounds and protein isolates depend heavily on international trade. Regions including Asia-Pacific and Europe are facing increased pricing challenges due to their reliance on imported health ingredients and formulation equipment. However, tariffs are also fostering localized food production, regional procurement of functional ingredients, and innovation within domestic nutraceutical manufacturing ecosystems.

The glucagon-like peptide-1 (glp) companion food and nutrition market research report is one of a series of new reports from The Business Research Company that provides glucagon-like peptide-1 (glp) companion food and nutrition market statistics, including glucagon-like peptide-1 (glp) companion food and nutrition industry global market size, regional shares, competitors with a glucagon-like peptide-1 (glp) companion food and nutrition market share, detailed glucagon-like peptide-1 (glp) companion food and nutrition market segments, market trends and opportunities, and any further data you may need to thrive in the glucagon-like peptide-1 (glp) companion food and nutrition industry. This glucagon-like peptide-1 (glp) companion food and nutrition market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The glucagon-like peptide-1 (GLP) companion food and nutrition market size has grown exponentially in recent years. It will grow from $3.2 billion in 2025 to $4.14 billion in 2026 at a compound annual growth rate (CAGR) of 29.2%. The growth in the historic period can be attributed to rising prevalence of obesity and type 2 diabetes globally, increasing adoption of pharmacological weight management therapies, growth in functional food and dietary supplement industry, early clinical success of GLP-1 receptor agonist drugs, increasing consumer awareness of metabolic health management.

The glucagon-like peptide-1 (GLP) companion food and nutrition market size is expected to see exponential growth in the next few years. It will grow to $11.66 billion in 2030 at a compound annual growth rate (CAGR) of 29.6%. The growth in the forecast period can be attributed to expansion of GLP-1 drug adoption for weight and diabetes care, rising demand for personalized nutrition and precision diet planning, growth of digital health and nutrition tracking platforms, increasing integration of food-tech and biotech innovations, expansion of preventive healthcare and metabolic wellness programs. Major trends in the forecast period include personalized metabolic nutrition planning for GLP-1 therapy support, satiety-enhancing functional food formulations with appetite regulation focus, low glycemic index meal systems designed for glucose stabilization, microbiome optimized dietary interventions for weight management support, protein enriched and nutrient dense GLP-1 companion diets for muscle preservation.

The increasing rate of obesity is expected to accelerate the growth of the glucagon-like peptide-1 (GLP) companion food and nutrition market going forward. Obesity is a medical condition characterized by an excessive accumulation of body fat that can adversely affect health and elevate the risk of diseases such as diabetes, cardiovascular disease, and hypertension. The rising prevalence of obesity is mainly driven by unhealthy eating habits, including excessive consumption of calorie-dense, processed, and sugary foods, along with insufficient levels of physical activity. Glucagon-like peptide-1 (GLP) companion food and nutrition contributes to obesity management by complementing GLP-1-based weight-loss therapies with high-protein and high-fiber nutritional formulations that promote satiety, reduce excessive food intake, and help maintain lean muscle mass during calorie restriction. For instance, in May 2025, according to the Office for Health Improvement and Disparities, a UK-based government body, between 2023 and 2024, an estimated 64.5% of adults aged 18 years and above in England were overweight or living with obesity, compared with 64.0% during 2022 to 2023. Therefore, the increasing rate of obesity is driving the growth of the oral glucagon-like peptide-1 (GLP) companion food and nutrition market.

Key companies operating in the glucagon-like peptide-1 (GLP) companion food and nutrition market are focusing on developing innovative nutritional support solutions, such as protein and fiber-enriched companion food combinations, to improve dietary balance, prevent muscle loss, and address potential nutrient deficiencies associated with GLP-1-based weight-loss therapies. Protein and fiber-enriched companion food combinations are specially formulated food products that contain increased levels of protein and dietary fiber to support nutrition, promote satiety, and improve digestive health, particularly for individuals with reduced food intake or specific nutritional requirements. For example, in February 2024, Herbalife Ltd., a US-based nutrition and wellness company, launched Herbalife GLP-1 Nutrition Companion, a range of food and supplement product combinations designed to support individuals using GLP-1 and other weight-loss medications. The product range includes protein shake-based formulations and fiber-enriched nutrition blends aimed at helping users fulfill daily nutritional needs while supporting muscle preservation and digestive health. The solution also incorporates community-based nutritional guidance through distributors to promote healthier eating practices during and after weight-loss treatment, supporting long-term lifestyle improvements beyond medication use.

In March 2023, WeightWatchers International Inc., a US-based wellness company, acquired Sequence Weekend Health Inc. for $132 million. Through this acquisition, WeightWatchers aims to transition from a traditional diet and weight-loss provider into a modern clinical weight-management platform. The company focuses on integrating prescription obesity treatments, including Glucagon Like Peptide-1 medications, through telehealth services and digital support tools. Sequence Weekend Health Inc. is a US-based clinical weight-loss and obesity care company that provides GLP-1 companion nutrition and weight-management support programs, including personalized nutrition guidance, protein and hydration targets, dietitian support, behavioral coaching, recipes, and GLP-1-specific lifestyle programs designed to complement GLP-1 medications.

Major companies operating in the glucagon-like peptide-1 (glp) companion food and nutrition market report are Nestle S.A., Danone S.A., Arla Foods amba, Glanbia plc, Herbalife Ltd., BellRing Brands Inc., The Simply Good Foods Company

North America was the dominating region in the glucagon-like peptide-1 (GLP) companion food and nutrition market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the glucagon-like peptide-1 (GLP) companion food and nutrition market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the glucagon-like peptide-1 (GLP) companion food and nutrition market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The glucagon-like peptide-1 (GLP) companion food and nutrition market consists of sales of nutrient-dense foods, medically formulated meal replacements, low-calorie snacks, and dietary supplements. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses glucagon-like peptide-1 (glp) companion food and nutrition market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for glucagon-like peptide-1 (glp) companion food and nutrition ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The glucagon-like peptide-1 (glp) companion food and nutrition market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: High Protein Foods; Glucagon Like Peptide One Optimized Meal Kits; Nutritional Supplements; Functional Beverages; Low Calorie Snacks
  • 2) By Consumer: Glucagon Like Peptide One Drug Users; Weight Management Seekers; Diabetic Patients; General Wellness Consumers
  • 3) By Formulation Focus: Satiety Support Products; Muscle Maintenance Products; Micronutrient Enhanced Products; Hydration Support Products; Digestive Comfort Products
  • 4) By Distribution Channel: Retail Pharmacies; Electronic Commerce; Specialty Health Stores; Direct To Consumer
  • Subsegments:
  • 1) By High Protein Foods: Protein Shakes; Protein Bars; High Protein Dairy Products; Protein Enriched Bakery Products; Plant Based Protein Foods
  • 2) By Glucagon Like Peptide One Optimized Meal Kits: Calorie Controlled Meal Kits; Diabetes Friendly Meal Kits; Portion Controlled Prepared Meals; Appetite Support Meal Plans; Metabolic Health Meal Kits
  • 3) By Nutritional Supplements: Vitamins And Minerals Supplements; Fiber Supplements; Amino Acid Supplements; Gut Health Probiotics; Weight Management Supplements
  • 4) By Functional Beverages: Protein Beverages; Electrolyte Drinks; Fiber Infused Drinks; Low Sugar Functional Juices; Metabolic Health Drinks
  • 5) By Low Calorie Snacks: Low Calorie Protein Snacks; Baked Snack Alternatives; Sugar Free Confectionery; Diet Friendly Savory Snacks; Portion Controlled Snack Packs
  • Companies Mentioned: Nestle S.A.; Danone S.A.; Arla Foods amba; Glanbia plc; Herbalife Ltd.; BellRing Brands Inc.; The Simply Good Foods Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Sustainability, Climate Tech & Circular Economy
  • 4.2. Major Trends
    • 4.2.1 Personalized Metabolic Nutrition Planning For Glp-1 Therapy Support
    • 4.2.2 Satiety-Enhancing Functional Food Formulations With Appetite Regulation Focus
    • 4.2.3 Low Glycemic Index Meal Systems Designed For Glucose Stabilization
    • 4.2.4 Microbiome Optimized Dietary Interventions For Weight Management Support
    • 4.2.5 Protein Enriched And Nutrient Dense Glp-1 Companion Diets For Muscle Preservation

5. Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Analysis Of End Use Industries

  • 5.1 GLP One Drug Users
  • 5.2 Weight Management Seekers
  • 5.3 Diabetic Patients
  • 5.4 General Wellness Consumers
  • 5.5 Healthcare And Nutrition Companies

6. Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition PESTEL Analysis (Political, Economical, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Segmentation

  • 9.1. Global Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • High Protein Foods, Glucagon Like Peptide One Optimized Meal Kits, Nutritional Supplements, Functional Beverages, Low Calorie Snacks
  • 9.2. Global Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Segmentation By Consumer, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Glucagon Like Peptide One Drug Users, Weight Management Seekers, Diabetic Patients, General Wellness Consumers
  • 9.3. Global Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Segmentation By Formulation Focus, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Satiety Support Products, Muscle Maintenance Products, Micronutrient Enhanced Products, Hydration Support Products, Digestive Comfort Products
  • 9.4. Global Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Retail Pharmacies, Electronic Commerce, Specialty Health Stores, Direct To Consumer
  • 9.5. Global Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Sub-Segmentation Of High Protein Foods, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Protein Shakes, Protein Bars, High Protein Dairy Products, Protein Enriched Bakery Products, Plant Based Protein Foods
  • 9.6. Global Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Sub-Segmentation Of Glucagon Like Peptide One Optimized Meal Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Calorie Controlled Meal Kits, Diabetes Friendly Meal Kits, Portion Controlled Prepared Meals, Appetite Support Meal Plans, Metabolic Health Meal Kits
  • 9.7. Global Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Sub-Segmentation Of Nutritional Supplements, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Vitamins And Minerals Supplements, Fiber Supplements, Amino Acid Supplements, Gut Health Probiotics, Weight Management Supplements
  • 9.8. Global Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Sub-Segmentation Of Functional Beverages, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Protein Beverages, Electrolyte Drinks, Fiber Infused Drinks, Low Sugar Functional Juices, Metabolic Health Drinks
  • 9.9. Global Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Sub-Segmentation Of Low Calorie Snacks, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Low Calorie Protein Snacks, Baked Snack Alternatives, Sugar Free Confectionery, Diet Friendly Savory Snacks, Portion Controlled Snack Packs

10. Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Regional And Country Analysis

  • 10.1. Global Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market

  • 11.1. Asia-Pacific Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Segmentation By Product Type, Segmentation By Consumer, Segmentation By Formulation Focus, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market

  • 12.1. China Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Segmentation By Product Type, Segmentation By Consumer, Segmentation By Formulation Focus, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market

  • 13.1. India Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Segmentation By Product Type, Segmentation By Consumer, Segmentation By Formulation Focus, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market

  • 14.1. Japan Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Segmentation By Product Type, Segmentation By Consumer, Segmentation By Formulation Focus, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market

  • 15.1. Australia Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Segmentation By Product Type, Segmentation By Consumer, Segmentation By Formulation Focus, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market

  • 16.1. Indonesia Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Segmentation By Product Type, Segmentation By Consumer, Segmentation By Formulation Focus, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market

  • 17.1. South Korea Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Segmentation By Product Type, Segmentation By Consumer, Segmentation By Formulation Focus, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market

  • 18.1. Taiwan Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Segmentation By Product Type, Segmentation By Consumer, Segmentation By Formulation Focus, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market

  • 19.1. South East Asia Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Segmentation By Product Type, Segmentation By Consumer, Segmentation By Formulation Focus, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market

  • 20.1. Western Europe Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Segmentation By Product Type, Segmentation By Consumer, Segmentation By Formulation Focus, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market

  • 21.1. UK Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Segmentation By Product Type, Segmentation By Consumer, Segmentation By Formulation Focus, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market

  • 22.1. Germany Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Segmentation By Product Type, Segmentation By Consumer, Segmentation By Formulation Focus, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market

  • 23.1. France Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Segmentation By Product Type, Segmentation By Consumer, Segmentation By Formulation Focus, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market

  • 24.1. Italy Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Segmentation By Product Type, Segmentation By Consumer, Segmentation By Formulation Focus, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market

  • 25.1. Spain Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Segmentation By Product Type, Segmentation By Consumer, Segmentation By Formulation Focus, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market

  • 26.1. Eastern Europe Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Segmentation By Product Type, Segmentation By Consumer, Segmentation By Formulation Focus, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market

  • 27.1. Russia Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Segmentation By Product Type, Segmentation By Consumer, Segmentation By Formulation Focus, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market

  • 28.1. North America Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Segmentation By Product Type, Segmentation By Consumer, Segmentation By Formulation Focus, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market

  • 29.1. USA Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Segmentation By Product Type, Segmentation By Consumer, Segmentation By Formulation Focus, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market

  • 30.1. Canada Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Segmentation By Product Type, Segmentation By Consumer, Segmentation By Formulation Focus, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market

  • 31.1. South America Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Segmentation By Product Type, Segmentation By Consumer, Segmentation By Formulation Focus, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market

  • 32.1. Brazil Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Segmentation By Product Type, Segmentation By Consumer, Segmentation By Formulation Focus, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market

  • 33.1. Middle East Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Segmentation By Product Type, Segmentation By Consumer, Segmentation By Formulation Focus, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market

  • 34.1. Africa Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market, Segmentation By Product Type, Segmentation By Consumer, Segmentation By Formulation Focus, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Regulatory and Investment Landscape

36. Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Competitive Landscape And Company Profiles

  • 36.1. Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Company Profiles
    • 36.3.1. Nestle S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Danone S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Arla Foods amba Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Glanbia plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Herbalife Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Other Major And Innovative Companies

  • BellRing Brands Inc., The Simply Good Foods Company

38. Global Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market

41. Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market High Potential Countries, Segments and Strategies

  • 41.1 Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market In 2030 - Countries Offering Most New Opportunities
  • 41.2 Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market In 2030 - Segments Offering Most New Opportunities
  • 41.3 Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market In 2030 - Growth Strategies
    • 41.3.1 Market Trend Based Strategies
    • 41.3.2 Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기